Pregnancy Rate in Endometriosis Patients according to the Severity of the Disease after Using a Combined Approach of Laparoscopy, GnRH Agonist Treatment and in vitro Fertilization

被引:15
|
作者
Soritsa, Deniss [1 ,3 ]
Saare, Merli [2 ,4 ]
Laisk-Podar, Triin [2 ,4 ]
Peters, Maire [2 ,4 ]
Soritsa, Andrei [3 ]
Matt, Kadri [1 ,4 ]
Karro, Helle [1 ,4 ]
Salumets, Andres [2 ,4 ]
机构
[1] Univ Tartu, Womens Clin Tartu Univ Hosp, EE-50090 Tartu, Estonia
[2] Univ Tartu, Competence Ctr Reprod Med & Biol, EE-50090 Tartu, Estonia
[3] Univ Tartu, Elite Clin, EE-50090 Tartu, Estonia
[4] Univ Tartu, Dept Obstet & Gynecol, EE-50090 Tartu, Estonia
关键词
Endometriosis; GnRH agonists; Infertility; In vitro fertilization; Laparoscopy; SURGICAL-TREATMENT; REPRODUCTIVE-PERFORMANCE; PREDICTIVE-VALUE; SURGERY; ADENOMYOSIS; INFERTILITY; THERAPY; WOMEN; IVF; CLASSIFICATION;
D O I
10.1159/000365329
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To evaluate the effects of combined treatment approaches on endometriosis-associated infertility in different stages of endometriosis using laparoscopy, gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy and in vitro fertilization (IVF). Methods: This retrospective study was carried out on 179 women with surgically confirmed endometriosis. Patients were divided into subgroups: group 1 (stage I-II, n = 121) and group 2 (stage III-IV, n = 58). Patients eligible for IVF, who were found to have adenomyosis or moderate to severe endometriosis, were also given postoperative GnRHa. Pregnancy and delivery rates were cumulatively calculated during 5 years according to the severity of the disease. Results: The overall pregnancy, delivery and miscarriage rates were 66.5, 56.4 and 15.1%, respectively, for all patients following spontaneous and assisted conception. There were no significant differences in reproductive outcomes between the study groups. The pregnancy and delivery rates were also comparable within group 1 between the patients with and without GnRHa treatment. Conclusion: Pregnancy and delivery rates at different stages of endometriosis were not affected by the different approaches used for infertility treatment, with >60 and >50% of patients having conceived and delivered a baby, respectively, in both groups. The usefulness of GnRHa treatment for endometriosis patients with minimal to mild forms is questionable and deserves further studies. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:34 / 39
页数:6
相关论文
共 22 条
  • [21] Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur(R)), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome
    Regidor, PA
    Regidor, M
    Kato, K
    Bier, UW
    Buhler, K
    Schindler, AE
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 73 (02): : 153 - 160
  • [22] The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
    Engmann, Lawrence
    DiLuigi, Andrea
    Schmidt, David
    Nulsen, John
    Maier, Donald
    Benadiva, Claudio
    FERTILITY AND STERILITY, 2008, 89 (01) : 84 - 91